Redwood Pharma
0.806 SEK -0.25%1 investor is following this company
Redwood Pharma is a pharmaceutical company. The main focus is on the production of ophthalmic pharmaceuticals. The products contain active substances that are used in the treatment of dry eye disease (DED), characterised by dryness, pain, and burning. The disorder is caused by inflammation due to dysfunction of the glands as well as by the usage of contact lenses. The company is based in Stockholm.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
REDW
Daily low / high price
0.776 / 0.818
SEK
Market cap
17.12M SEK
Turnover
37.39K SEK
Volume
47K
Financial calendar
Interim report
2024-05-08
General meeting
2024-05-29
Interim report
2024-08-29
Interim report
2024-11-13
Annual report
2025-02-12
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 14.7 % | 14.7 % |
Martin Vidaeus | 2.6 % | 2.6 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Redwood Pharma offentliggör memorandum avseende företrädesemission av units
Kommuniké från extra bolagsstämma i Redwood Pharma AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools